The quality of life after breast cancer -- solving the problem of lymphedema
Article Abstract:
More research is needed to find effective ways of treating lymphedema in breast cancer patients. Many breast cancer patients have surgery to determine if the cancer has spread to the lymph nodes under the arm. However, this sometimes damages the lymphatic system, causing fluid to buildup in the arm. The resulting swelling is called lymphedema. A 1999 study found that the anticoagulant drug coumarin was not effective in reducing this swelling. As more cases of breast cancer are detected early, fewer women will have surgery on their lymph nodes and the incidence of lymphedema may decrease.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
A 67-year-old woman with increasing neurologic deficits and a history of breast and ovarian cancer
Article Abstract:
A 67-year-old woman was admitted to a hospital with a history of breast and ovarian cancer and increasing confusion and other neurologic symptoms. An abdominal CT scan revealed a mass which was assumed to be a recurrence of her ovarian cancer. An MRI scan of the brain showed abnormalities typical of an infarct, which is an area deprived of blood due to a blood clot that blocks blood flow. She died two days later, and an autopsy revealed blood clots in her brain and clumps of blood clots on her heart valves.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Tamoxifen in the treatment of breast cancer
Article Abstract:
Tamoxifen is a drug that inhibits the action of estrogen. Estrogen often stimulates tumors and this is true of most breast tumors. Tamoxifen can lower the risk of cancer recurrence in women who have localized disease that can be treated surgically. The drug also seems to be effective in lowering death and recurrence rates in women with more severe disease. Only women whose tumors contain estrogen receptors will benefit. Side effects include menopausal symptoms and endometrial cancer.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The quality of a table: a cautionary tale of good science. Observations on the physics of the surgical residency
- Abstracts: Readability of breast self-exam literature. Low molecular weight heparins: the future of thromboembolic therapy
- Abstracts: Can you eat your way to a better mood? In - the mood food. 6 shortcuts to a better mood
- Abstracts: Application of caring theory in primary care: a challenge for advanced practice. Professional practice leader: a transformational role that addresses human diversity
- Abstracts: National health policy: lessons from a hot seat. Target practice. Using the vision of healthy people to build healthier communities